AI-Powered Medical Platform OpenEvidence Secures $210M as Physician Adoption Soars
Summary
OpenEvidence raised $210 million in Series B funding at a $3.5 billion valuation. The company provides an AI-powered medical search platform that helps physicians synthesize medical literature into clinical insights. It says the product now supports millions of consultations each month and is used daily by a large share of U.S. physicians. The company also launched DeepConsult, a private AI agent team for medical research, while positioning the service as free for verified U.S. doctors. The article highlights both strong adoption and the challenge of converting that usage into sustainable enterprise revenue.
Funding
Amount
$210.0M
Total raised
Date
July 15, 2025
Announcement date
Investors
Thrive, Thrive Capital, Coatue Management, GV
Lead investors
Company
openevidence.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected